University of Birmingham: Innovative 'Gene-silencing' Therapy to Target Chronic Pain in Osteoarthritis
June 04, 2025
June 04, 2025
BIRMINGHAM, England, June 4 -- The University of Birmingham issued the following news:
* * *
Innovative 'gene-silencing' therapy to target chronic pain in osteoarthritis
A new peptide-siRNA drug delivery system could revolutionise treatment for osteoarthritis by targeting pain and inflammation at the source.
A new University of Birmingham-led study could pave the way for a targeted treatment for osteoarthritis (OA) that directly tackl . . .
* * *
Innovative 'gene-silencing' therapy to target chronic pain in osteoarthritis
A new peptide-siRNA drug delivery system could revolutionise treatment for osteoarthritis by targeting pain and inflammation at the source.
A new University of Birmingham-led study could pave the way for a targeted treatment for osteoarthritis (OA) that directly tackl . . .